Pay in 4 interest-free payments of $5.04 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
As a GLP-1, GIP, and glucagon receptor agonist being evaluated for obesity and type 2 diabetes, retatrutide shares some skin-related adverse effects with other subcutaneous incretin therapies, whilst its full dermatological profile remains under investigation
The cheapest verified options without insurance in 2026 are compounded tirzepatide through a licensed telehealth program starting from $259 per month and LillyDirect Zepbound vials starting from $299 per month
Oligomerization of Alzheimers beta-amyloid within processes and synapses of cultured neurons and brain
This lipid-lowering drug, in addition to lipid control, is used as an adjunct therapy for reducing plasma glucose levels in T2D [183]
Get a Quote Retatrutide 10mg Investigational triple agonist acting at the GLP-1, GIP, and glucagon receptors
US$ 22.14
US$ 28.19
US$ 21.25
